Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial. Raposeiras Roubin S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al. Circulation 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.

Read + Share

Amedeo Smart

Independent Medical Education

Raposeiras Roubin S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al. Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial. Circulation 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
PMID: 41200807